Decade Resources Ltd. reported that it has received the assays from the recent drill program at the Nobody Knows No 1 and Nobody Knows No 2 zones at the Copper River project. The project is part of a large claim holding consisting of 52 contiguous minerals claims which include Nobody Knows, Dardanelle (presently farmed out) and Treasure Mountain properties totaling 23,016.7 hectares. All 52 mineral claims are 100% owned by Decade Resources Ltd. The project stretches from 10 to 40 air kilometers east of Terrace, B.C., on the northern slopes of the Copper River valley.

Mineralization is dominated by bornite, chalcocite and malachite with lesser covellite and chalcopyrite and little to no pyrite. These sulphides constitute from trace to 5% of the rock forming grains, small blebs and veinlets which show strong association with silicification and shearing. This type of mineralization does not contain any appreciable gold but is enriched in silver fitting the model of a red bed type copper- silver mineralized system.

Assays for the entire 33 drill holes are shown in the table below with assays 0.1% Cu listed. DDH-23-NB-1-22 inclusive and DDH-NB-23-31-33 inclusive are over the Nobody Knows # 2 showing. DDH-NB-23-26 inclusive tested small copper showings along the West Copper River Forestry road and DDH-23-NB-27-30 inclusive tested the Nobody Knows # 1 showing, 1.2 km east of the Nobody Knows 2 showing.

For the latter 2 drill areas, only drilling on the Nobody Knows # 1 showing intersected short intervals of higher grade copper within chalcopyrite bearing limestone fragments in a highly epidote altered andesite. For DDH-23-33 was terminated early due to freeze up conditions. Based on drilling, the Nobody knows # 2 zone is not related to mineralization at the Nobody Knows # 1 zone as initially interpreted.

The strike zone from the Nobody Knows # 2 zone to the previous drilling at Treasure Mountain is approximately 20 km east. The Company is currently assessing targets on Treasure Mountain to be included in the 2024 drill program. All samples were analyzed by ALS Labs in North Vancouver BC.